Liver-directed Overexpression of Mitochondrial Glycerol-3-phosphate Acyltransferase Results in Hepatic Steatosis, Increased Triacylglycerol Secretion and Reduced Fatty Acid Oxidation.
From: Department of Integrative Pharmacology, AstraZeneca R&D, S-431 83 Mölndal, Sweden. daniel.linden@astrazeneca.com
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- Publish Date: Mar 2006
- ISSN: 1530-6860
- Volume: 20
- Issue: 3
- Pages: 434-43
- Medium: Internet
- Language: English
- Citation (JAMA): Lindén Daniel, William-Olsson Lena, Ahnmark Andrea, et al. Liver-directed Overexpression of Mitochondrial Glycerol-3-phosphate Acyltransferase Results in Hepatic Steatosis, Increased Triacylglycerol Secretion and Reduced Fatty Acid Oxidation.. FASEB J. Mar 2006;20:434-43
Abstract
Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the first committed step in triacylglycerol (TAG) and phospholipid biosynthesis. GPAT activity has been identified in both ER and mitochondrial subcellular fractions. The ER activity dominates in most tissues except in liver, where the mitochondrial isoform (mtGPAT) can constitute up to 50% of the total activity. To study the in vivo effects of hepatic mtGPAT overexpression, mice were transduced with adenoviruses expressing either murine mtGPAT or a catalytically inactive variant of the enzyme. Overexpressing mtGPAT resulted in massive 12- and 7-fold accumulation of liver TAG and diacylglycerol, respectively but had no effect on phospholipid or cholesterol ester content. Histological analysis showed extensive lipid accumulation in hepatocytes. Furthermore, mtGPAT transduction markedly increased adipocyte differentiation-related protein and stearoyl-CoA desaturase-1 (SCD-1) in the liver. In line with increased SCD-1 expression, 18:1 and 16:1 in the hepatic TAG fraction increased. In addition, mtGPAT overexpression decreased ex vivo fatty acid oxidation, increased liver TAG secretion rate 2-fold, and increased plasma TAG and cholesterol levels. These results support the hypothesis that increased hepatic mtGPAT activity associated with obesity and insulin resistance contributes to increased TAG biosynthesis and inhibition of fatty acid oxidation, responses that would promote hepatic steatosis and dyslipidemia.
Mesh Headings (Keywords): Amino Acid Substitution, Animals, Carbohydrates, Diglycerides, Enzyme Induction, Fatty Acids, Fatty Liver, Glycerol-3-Phosphate O-Acyltransferase, Insulin Resistance, Lipids, Male, Malonyl Coenzyme A, Mass Spectrometry, Mice, Mice, Inbred C57BL, Mitochondria, Liver, Obesity, Oxidation-Reduction, Phospholipids, RNA, Messenger, Recombinant Fusion Proteins, Triglycerides
Check for Full Text / PubMed Unique Identifier (PMID): 16507761
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.